Tuesday, December 06, 2016 11:19:42 AM
Huh? My feathers aren't ruffled and I never said you were being confrontational. I am giving factual information that anybody can verify or ignore.
Yes. Earlier in the year they had stated they hoped to be revenue-neutral by the end of the year for CybeRisk and I pointed out that guidance from a call a couple months ago where they stated "could be millions" by the end of the year. It isn't the end of the year yet. We don't know what CybeRisk is doing in 4Q yet. They obviously guided that revenue would be picking up near the end of the year. I'm not concerned if it is recognized in this quarter or next as long as they can give some positive guidance on number of clients and/or contracted revenue even if it gets spread out over a few quarters.
Feel free to jump on guidance for periods that have not finished yet. I feel this is grossly unfair, but you are welcome to have whatever opinion you wish.
Of course I do. They are going to pay millions to use the cash for over a year. The alternative would have been about a 50% dilution in outstanding shares. When the preferred shares are all redeemed there will still be only 23M shares outstanding. It was a GREAT deal for shareholders under the circumstances.
Once again... you are entitled to whatever opinion you wish. I will keep posting verifiable facts directly from publicly available information and sprinkle in my own opinions on how they relate to the future prospects. Good luck to you.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM